Novartis : NVS

All Novartis Articles

136 Articles

Lee Jackson | Apr 5, 2016 at 8:55 AM EDT

Top Analysts Upgrades and Downgrades: AT&T, Capital One, Cisco, Novartis, Sprint, Starbucks and More

Tuesday’s top analyst upgrades, downgrades and initiations include AT&T, Capital One, Cisco, Novartis, Sprint and Starbucks.

Jon C. Ogg | Apr 1, 2016 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Capital One, Energen, Micron, Salesforce.com, United Continental, United Rentals, Viacom and More

The top analyst upgrades, downgrades and initiations seen on Friday morning include Capital One, Energen, Micron Technology, Salesforce.com, United Continental,…

Jon C. Ogg | Mar 23, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Schwab, Dean Foods, HollyFrontier, Incyte, Newfield Exploration, Nike and More

The top analyst upgrades, downgrades and initiations seen on Wednesday, March 23, include Charles Schwab, Dean Foods, HollyFrontier, Incyte, Newfield…

Chris Lange | Mar 15, 2016 at 9:25 AM EDT

Jefferies Top Drug Stocks for the Rest of 2016

For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made…

Jon C. Ogg | Jan 15, 2016 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Best Buy, 3D Systems, EA, Gilead, Nokia, Shire, United Rentals and Many More

Friday's top analyst calls include Best Buy, 3D Systems, Electronic Arts, Gilead Sciences, Nokia, Shire and United Rentals.

Trey Thoelcke | Jan 5, 2016 at 9:15 AM EST

4 Stocks to Help You Sleep Easy as Market Falls

Here are four stocks that will help you sleep easy regardless of how the broader indexes perform for the rest…

Chris Lange | Dec 7, 2015 at 4:09 PM EST

Jefferies Top Pharma Stock Picks for 2016

Brokerage firm Jefferies has released its top pharmaceutical picks for the coming year and what to expect.

Jon C. Ogg | Aug 24, 2015 at 3:04 PM EDT

FDA Grants Expanded Use of Promacta for Novartis

ThinkstockNovartis AG (NYSE: NVS) is one of the few companies with good news on a major market sell-off. Unfortunately, it…

Chris Lange | Aug 17, 2015 at 9:45 AM EDT

Is AVEO the Next Aquinox for Traders?

Aveo Pharmaceuticals made waves in early trading indications Monday on news of a licensing agreement with Novartis.

Jon C. Ogg | Aug 4, 2015 at 3:44 PM EDT

Will Biogen Win From Novartis MS Drug Safety Label Change?

ThinkstockThere are times when a negative piece of news in the BioPharma sector can actually help rival companies. Biogen Inc.…

Chris Lange | Jul 8, 2015 at 4:12 PM EDT

Meet the Next Mega Blockbuster Heart Drug

Novartis is getting ready to steal a lot of hearts with its newest drug. The FDA has approved Entresto tablets…

Lee Jackson | Mar 2, 2015 at 10:20 AM EST

5 Dividend Stocks to Buy as European Index Crushes S&P 500

Owning a few top European stocks in a well-balanced portfolio makes good sense at this juncture, especially with the U.S.…

Lee Jackson | Jan 7, 2015 at 10:35 AM EST

Analyst’s 8 Top Health Care Stocks for 2015

A new research report from the analysts at Cowen highlights the firm's top health care picks, many of which have…

Chris Lange | Jan 5, 2015 at 4:25 PM EST

Is a Generic Diovan for You?

What are investors, and patients, supposed to think when is launching a generic version of Diovan?

Chris Lange | Dec 4, 2014 at 10:35 AM EST

Array BioPharma: When Losing a Partnership Is Good News

Array BioPharma has announced that it had reached a definitive agreement with Novartis to regain full worldwide rights to cancer…

1 … 3 4 5 6 7 … 10

Novartis : NVS

All Novartis Articles

Top Analysts Upgrades and Downgrades: AT&T, Capital One, Cisco, Novartis, Sprint, Starbucks and More

Top Analyst Upgrades and Downgrades: Capital One, Energen, Micron, Salesforce.com, United Continental, United Rentals, Viacom and More

Top Analyst Upgrades and Downgrades: Schwab, Dean Foods, HollyFrontier, Incyte, Newfield Exploration, Nike and More

Jefferies Top Drug Stocks for the Rest of 2016

Top Analyst Upgrades and Downgrades: Best Buy, 3D Systems, EA, Gilead, Nokia, Shire, United Rentals and Many More

4 Stocks to Help You Sleep Easy as Market Falls

Jefferies Top Pharma Stock Picks for 2016

FDA Grants Expanded Use of Promacta for Novartis

Is AVEO the Next Aquinox for Traders?

Will Biogen Win From Novartis MS Drug Safety Label Change?

Meet the Next Mega Blockbuster Heart Drug

5 Dividend Stocks to Buy as European Index Crushes S&P 500

Analyst’s 8 Top Health Care Stocks for 2015

Is a Generic Diovan for You?

Array BioPharma: When Losing a Partnership Is Good News

Social Security’s Timetable for Collapse Just Moved Up – and That’s Not Even the Worst News

“He’s a Wolf in the Middle of the Sheep Pen”: Dave Ramsey to a Church Elder Watching a Fellow Member Sell Whole Life Insurance to Congregants

Here’s How You Can Retire to St. Petersburg, Florida, at 65 on $925,000 Where the Sun Shines

Social Security's Timetable for Collapse Just Moved Up - and That's Not Even the Worst News

"He's a Wolf in the Middle of the Sheep Pen": Dave Ramsey to a Church Elder Watching a Fellow Member Sell Whole Life Insurance to Congregants

Social Security’s Timetable for Collapse Just Moved Up – and That’s Not Even the Worst News

“He’s a Wolf in the Middle of the Sheep Pen”: Dave Ramsey to a Church Elder Watching a Fellow Member Sell Whole Life Insurance to Congregants

Novartis : NVS

All Novartis Articles

Top Analysts Upgrades and Downgrades: AT&T, Capital One, Cisco, Novartis, Sprint, Starbucks and More

Top Analyst Upgrades and Downgrades: Capital One, Energen, Micron, Salesforce.com, United Continental, United Rentals, Viacom and More

Top Analyst Upgrades and Downgrades: Schwab, Dean Foods, HollyFrontier, Incyte, Newfield Exploration, Nike and More

Jefferies Top Drug Stocks for the Rest of 2016

Top Analyst Upgrades and Downgrades: Best Buy, 3D Systems, EA, Gilead, Nokia, Shire, United Rentals and Many More

4 Stocks to Help You Sleep Easy as Market Falls

Jefferies Top Pharma Stock Picks for 2016

FDA Grants Expanded Use of Promacta for Novartis

Is AVEO the Next Aquinox for Traders?

Will Biogen Win From Novartis MS Drug Safety Label Change?

Meet the Next Mega Blockbuster Heart Drug

5 Dividend Stocks to Buy as European Index Crushes S&P 500

Analyst’s 8 Top Health Care Stocks for 2015

Is a Generic Diovan for You?

Array BioPharma: When Losing a Partnership Is Good News

Social Security’s Timetable for Collapse Just Moved Up – and That’s Not Even the Worst News

“He’s a Wolf in the Middle of the Sheep Pen”: Dave Ramsey to a Church Elder Watching a Fellow Member Sell Whole Life Insurance to Congregants

Here’s How You Can Retire to St. Petersburg, Florida, at 65 on $925,000 Where the Sun Shines

Featured Reads

Social Security's Timetable for Collapse Just Moved Up - and That's Not Even the Worst News

"He's a Wolf in the Middle of the Sheep Pen": Dave Ramsey to a Church Elder Watching a Fellow Member Sell Whole Life Insurance to Congregants